Wellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.



SEOUL, South Korea, March 8, 2024 /PRNewswire/ — Wellysis, a digital healthcare company spun off from Samsung, has announced the launch of remote cardiac monitoring service in the US in partnership with Artella Solutions (ARTELLA).

This collaboration builds on its FDA-cleared S-Patch electrocardiogram monitoring solution, now featuring the newly FDA-cleared S-Patch ExL device. The ExL model allows for extended testing …

Full story available on Benzinga.com


Leave a Reply

Your email address will not be published. Required fields are marked *